Trial Profile

A clinical trial assessing HBM9378 in chronic obstructive pulmonary disease

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 12 Aug 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs HBM-9378 (Primary)
Indications Chronic obstructive pulmonary disease
Focus Therapeutic Use

Most Recent Events

23 Jul 2025 According to Sichuan Kelun-Biotech Biopharmaceutical media release, in January 2025, an IND application for SKB378/WIN378 for the treatment of COPD was approved by the National Medical Products Administration (NMPA).
23 Jul 2025 According to Sichuan Kelun-Biotech Biopharmaceutical media release, the trial is planned to start in 2026.
21 Jan 2025 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com